Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living Humans
John Leonard built Intellia Therapeutics with Jennifer Doudna, the Nobel Prize-winning scientist who pioneered gene editing technology. Intellia has figured out how to alter disease-causing genes inside patients, but before any breakthrough treatments come, it must cure itself of financial ills.
BETA This is a BETA experience. opt-out here Innovation Healthcare Daily Cover By Aayushi Pratap , Former Staff. I write on health impacts of climate change & infectious diseases. Jun 16, 2022, 06:34am EDT Updated Jun 16, 2022, 06:10pm EDT John Leonard built Intellia Therapeutics with Jennifer Doudna, the Nobel Prize-winning scientist who pioneered gene editing technology. The company has figured out how to alter disease-causing genes inside patients, but before any breakthrough treatments come, it must first cure itself of its legal and financial ills. J ohn Leonard, CEO of Intellia Thera
saved by
related reading
- Significantly Enhancing Adult Intelligence With Gene Editing May Be Possible — LessWronglesswrong.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Dyno Therapeutics: The Capsids You Needcenturyofbio.com
- George Church: The Future Without Limit | Innovators | National Geographicnationalgeographic.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
- New tools for programming biology - by Elliot Hershbergcenturyofbio.com
- The Business of RNAi Therapeutics in 2012ncbi.nlm.nih.gov
- CRISPR Gene Therapy: Applications, Limitations, and Implications for the Futurencbi.nlm.nih.gov
- The Dawn of Engineered Biology | Contrary Researchcontrary.com
- An ancient RNA-guided system could simplify delivery of gene editing therapiesbroadinstitute.org
- The current state and future directions of RNAi-based therapeutics | Nature Reviews Drug Discoverynature.com